Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 1–35 of 35 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05675787	Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia	unknown	Phase 2	82	Peking University People's HospitalOTHER	1	Jul 11, 2024	clinicaltrials
NCT05955105	A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies	unknown	Phase 1 / Phase 2	200	Innolake BiopharmINDUSTRY	1	May 21, 2024	clinicaltrials